1. Home
  2. VERU vs AMTD Comparison

VERU vs AMTD Comparison

Compare VERU & AMTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • AMTD
  • Stock Information
  • Founded
  • VERU 1971
  • AMTD 2003
  • Country
  • VERU United States
  • AMTD France
  • Employees
  • VERU N/A
  • AMTD N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • AMTD
  • Sector
  • VERU Health Care
  • AMTD
  • Exchange
  • VERU Nasdaq
  • AMTD Nasdaq
  • Market Cap
  • VERU 76.9M
  • AMTD 77.3M
  • IPO Year
  • VERU 1990
  • AMTD 2019
  • Fundamental
  • Price
  • VERU $0.54
  • AMTD $1.01
  • Analyst Decision
  • VERU Strong Buy
  • AMTD
  • Analyst Count
  • VERU 3
  • AMTD 0
  • Target Price
  • VERU $4.33
  • AMTD N/A
  • AVG Volume (30 Days)
  • VERU 2.0M
  • AMTD 13.0K
  • Earning Date
  • VERU 05-07-2025
  • AMTD 05-12-2025
  • Dividend Yield
  • VERU N/A
  • AMTD N/A
  • EPS Growth
  • VERU N/A
  • AMTD N/A
  • EPS
  • VERU N/A
  • AMTD N/A
  • Revenue
  • VERU $16,886,419.00
  • AMTD $46,925,000.00
  • Revenue This Year
  • VERU N/A
  • AMTD N/A
  • Revenue Next Year
  • VERU N/A
  • AMTD N/A
  • P/E Ratio
  • VERU N/A
  • AMTD $0.85
  • Revenue Growth
  • VERU 22.46
  • AMTD N/A
  • 52 Week Low
  • VERU $0.45
  • AMTD $0.95
  • 52 Week High
  • VERU $1.75
  • AMTD $1.97
  • Technical
  • Relative Strength Index (RSI)
  • VERU 49.37
  • AMTD 45.14
  • Support Level
  • VERU $0.51
  • AMTD $0.98
  • Resistance Level
  • VERU $0.56
  • AMTD $1.04
  • Average True Range (ATR)
  • VERU 0.04
  • AMTD 0.04
  • MACD
  • VERU 0.00
  • AMTD 0.00
  • Stochastic Oscillator
  • VERU 38.00
  • AMTD 60.10

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About AMTD AMTD IDEA Group each representing six (6)

AMTD IDEA Group is a financial institution operating in five business segments: The capital market solutions segment assists customers in raising funds through equity and debt financing, private placements, and debt issuances. The digital solutions and other services segment provides institutional and corporate clients with paid access to enhance investor communication and relations, corporate communication also provides digital financial solution services. The Media and entertainment segment offers print and digital advertising campaigns, licensing, and marketing services including branded content, video production. The hotel operations, hospitality, and VIP services segment engages in hotel investments, hotel operations, hospitality, and VIP services; and Strategic investment segment.

Share on Social Networks: